BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16410791)

  • 21. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.
    Campbell TB; Borok M; White IE; Gudza I; Ndemera B; Taziwa A; Weinberg A; Gwanzura L
    Clin Infect Dis; 2003 May; 36(9):1144-51. PubMed ID: 12715309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
    Fiorelli V; Gendelman R; Sirianni MC; Chang HK; Colombini S; Markham PD; Monini P; Sonnabend J; Pintus A; Gallo RC; Ensoli B
    Blood; 1998 Feb; 91(3):956-67. PubMed ID: 9446657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.
    Blumenthal MJ; Schutz C; Meintjes G; Mohamed Z; Mendelson M; Ambler JM; Whitby D; Mackelprang RD; Carse S; Katz AA; Schäfer G
    Cancer Epidemiol; 2018 Oct; 56():133-139. PubMed ID: 30176543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.
    Pellet C; Chevret S; Francès C; Euvrard S; Hurault M; Legendre C; Dalac S; Farge D; Antoine C; Hiesse C; Peraldi MN; Lang P; Samuel D; Calmus Y; Agbalika F; Morel P; Calvo F; Lebbé C
    J Infect Dis; 2002 Jul; 186(1):110-3. PubMed ID: 12089670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS.
    Chang Y; Moore PS
    Infect Agents Dis; 1996 Oct; 5(4):215-22. PubMed ID: 8884366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions.
    Pak F; Mwakigonja AR; Kokhaei P; Hosseinzadeh N; Pyakurel P; Kaaya E; Bogdanovic G; Selivanova G; Biberfeld P
    Eur J Cancer; 2007 Aug; 43(12):1877-82. PubMed ID: 17627810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.
    Parravicini C; Olsen SJ; Capra M; Poli F; Sirchia G; Gao SJ; Berti E; Nocera A; Rossi E; Bestetti G; Pizzuto M; Galli M; Moroni M; Moore PS; Corbellino M
    Blood; 1997 Oct; 90(7):2826-9. PubMed ID: 9326251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
    Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
    J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-Genome Sequencing of Kaposi's Sarcoma-Associated Herpesvirus from Zambian Kaposi's Sarcoma Biopsy Specimens Reveals Unique Viral Diversity.
    Olp LN; Jeanniard A; Marimo C; West JT; Wood C
    J Virol; 2015 Dec; 89(24):12299-308. PubMed ID: 26423952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor A polymorphism and risk of Kaposi's sarcoma herpesvirus viremia in kidney allograft recipients.
    Alkharsah KR; Alzahrani AJ; Obeid OE; El-Harith EH; Guella A; Mohamed EA; Haykal AH; Stuhrmann M; Al-Ali AK
    Transpl Infect Dis; 2014 Oct; 16(5):783-9. PubMed ID: 25124076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
    Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
    Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of Kaposi's sarcoma-associated herpesvirus viremia during hematopoietic stem cell mobilization with filgrastim.
    Neid JM; Schooley RT; Campbell TB
    Am J Hematol; 2004 Dec; 77(4):410-2. PubMed ID: 15551282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
    Okroj M; Tedeschi R; Mancuso R; Brambilla L; Tourlaki A; Dillner J; Blom AM
    Vaccine; 2011 Feb; 29(6):1129-34. PubMed ID: 21134448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Search for Kaposi's sarcoma-associated virus DNA in hemangioproliferative disorders and cutaneous malignant lymphoma.
    Serfling U; Lukowsky A; Audring H; Sterry W
    J Cutan Pathol; 1997 May; 24(5):298-304. PubMed ID: 9194583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus in organ transplant patients with immunosuppression.
    Alkan S; Karcher DS; Ortiz A; Khalil S; Akhtar M; Ali MA
    Br J Haematol; 1997 Feb; 96(2):412-4. PubMed ID: 9029034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.
    Bourboulia D; Aldam D; Lagos D; Allen E; Williams I; Cornforth D; Copas A; Boshoff C
    AIDS; 2004 Feb; 18(3):485-93. PubMed ID: 15090801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
    Gramolelli S; Ojala PM
    Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.